Forget the Centrica share price! I’d invest in these UK shares instead

Instead of Centrica, I’d rather look for enduring FTSE investments in stronger sectors. And here are some ideas for investment choices right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Centrica (LSE: CNA) share price has been engaged in a relentless down-trend for around seven years. Since the autumn of 2013, the stock has fallen by around 90%, crashing out of the FTSE 100 this year on the way down.

You don’t need me to tell you it’s been a terrible investment for its shareholders. And I wouldn’t rush in to buy the shares now for their recovery potential. Indeed, the company has been suffering from poor trading for a long while.

Why the Centrica share price has been falling

Customers have been abandoning the company’s energy supply arm, British Gas. And the firm’s upstream operations have suffered from weaker oil prices. Of course, the arrival of the Covid-19 pandemic hasn’t helped matters, but Centric is trying hard to turn its business around.

Part of the strategy involves simplifying operations with asset sales. And the recently announced agreement to sell the North American energy supply, services and trading business, Direct Energy, will help. The deal is worth around £2.85bn and will go some way to reduce Centrica’s gargantuan debt on its balance sheet.

However, less encouraging is the news that the divestment process for the its Nuclear assets has been “paused”. And the firm’s Spirit Energy E&P divestment process will restart “once commodity and financial markets have settled.” I can’t help thinking we’ll be in for a long wait for that one.

Generally, I’m not a big fan of investing in businesses that have been under-performing for years in the hope they can turn themselves around. And I’m even less enthused by the idea when a company carries a big weight of debt like Centrica does. The company may succeed, but it operates in a difficult and cyclical sector.

Here’s where I’d invest right now

Instead, I’d rather look for enduring FTSE investments in stronger sectors. For example, medical devices company Smith & Nephew looks set to recover well from the coronavirus setback. City analysts have pencilled in a more than 50% resurge in earnings for 2021, which should move profits higher than before the crisis. Meanwhile, the share price continues to languish well down from its highs.

In the fast-moving consumer goods sector, there are a couple of interesting recovery plays I’d go for instead of Centrica. One is the FTSE 250’s PZ Cussons, which has been rising on turnaround hopes after experienced FMCG chief executive Jonathon Myers took the helm in May.  And I like the look of Premier Foods, which is experiencing resurgent profits following a programme to re-vitalise its brands. The company is further along the recovery trail than PZ Cussons but still looks like a decent investment to me.

There are many other shares I’d rather buy than Centrica too. But in the current environment with coronavirus and general economic weakness, I’d also be interested in buying tracker funds. Sometimes broad-brush investing can be a good option, particularly if you hold your investments for decades. For example, I’d be keen to find trackers that follow the FTSE 100 index, the FTSE 250 and America’s S&P 500 to begin with.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold owns shares in PZ Cussons. The Motley Fool UK has recommended PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »